Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15 Rectal Neoplasms 14 Colonic Neoplasms 14 Stomach Neoplasms 10 Ovarian Neoplasms 7 Carcinoma, Hepatocellular 5 Gastrointestinal Stromal Tumors 4 Carcinoma, Renal Cell 4 Peritoneal Neoplasms 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Neoplastic Cells, Circulating 2 Neoplasms 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1 Ovarian Cysts 1 Obesity, Morbid 1 Neoplasm Metastasis 1

Interventions

Gemcitabine 60 Cisplatin 38 Oxaliplatin 30 Capecitabine 28 Fluorouracil 21 Leucovorin 19 pembrolizumab 11 Irinotecan 11 durvalumab 9 130-nm albumin-bound paclitaxel 9 Erlotinib Hydrochloride 8 Trastuzumab 7 Bevacizumab 7 Platinum 6 Magnetic Resonance Spectroscopy 6 Albumin-Bound Paclitaxel 6 1,2-diaminocyclohexaneplatinum II citrate 6 Taxes 5 Specimen Handling 5 Sorafenib 5 Radiotherapy 5 Carboplatin 5 Docetaxel 4 Biopsy 4 trifluridine tipiracil drug combination 3 dehydroftorafur 3 atezolizumab 3 Paclitaxel 3 Lapatinib 3 Interleukin-12 Subunit p35 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gallbladder Neoplasms × Laparoscopy × Clear all

NCT02867865 2025-03-13

POLCAGB

Tata Memorial Hospital

Phase 2/3 Active not recruiting

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡